Guggenheim Capital’s Acadia Healthcare ACHC Stock Holding History

Guggenheim Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$492K	Sell	21,030 -42,663	-67%	-$772K	﹤0.01%	1209
2025 Q4	$904K	Buy	63,693 +41,824	+191%	+$791K	0.01%	995
2025 Q3	$541K	Sell	21,869 -826	-4%	-$18.4K	﹤0.01%	1150
2025 Q2	$515K	Buy	22,695 +711	+3%	+$16.8K	﹤0.01%	1179
2025 Q1	$667K	Buy	21,984 +785	+4%	+$29.9K	0.01%	1065
2024 Q4	$841K	Sell	21,199 -2,546	-11%	-$115K	0.01%	995
2024 Q3	$1.51M	Sell	23,745 -441	-2%	-$31.8K	0.01%	930
2024 Q2	$1.63M	Sell	24,186 -16,866	-41%	-$1.18M	0.01%	888
2024 Q1	$3.25M	Buy	41,052 +25,901	+171%	+$2.12M	0.02%	719
2023 Q4	$1.18M	Buy	15,151 +4,251	+39%	+$315K	0.01%	1069
2023 Q3	$766K	Sell	10,900 -137	-1%	-$10.2K	0.01%	1217
2023 Q2	$879K	Sell	11,037 -3,445	-24%	-$249K	0.01%	1228
2023 Q1	$1.05M	Buy	14,482 +10,838	+297%	+$845K	0.01%	1159
2022 Q4	$300K	Sell	3,644 -16,416	-82%	-$1.35M	﹤0.01%	1671
2022 Q3	$1.57M	Sell	20,060 -519	-3%	-$41.5K	0.01%	940
2022 Q2	$1.39M	Sell	20,579 -736	-3%	-$51.3K	0.01%	1066
2022 Q1	$1.4M	Buy	21,315 +107	+0.5%	+$6.22K	0.01%	1202
2021 Q4	$1.29M	Sell	21,208 -491	-2%	-$29.3K	0.01%	1259
2021 Q3	$1.38M	Sell	21,699 -647	-3%	-$40.8K	0.01%	1247
2021 Q2	$1.4M	Buy	22,346 +1,281	+6%	+$80.3K	0.01%	1297
2021 Q1	$1.2M	Buy	21,065 +9,793	+87%	+$530K	0.01%	1299
2020 Q4	$566K	Buy	+11,272	New	+$449K	﹤0.01%	1584
2020 Q3	–	Sell	-8,050	Closed	-$202K	–	1913
2020 Q2	$202K	Sell	8,050 -3,901	-33%	-$97.4K	﹤0.01%	1745
2020 Q1	$219K	Sell	11,951 -7,018	-37%	-$201K	﹤0.01%	1646
2019 Q4	$630K	Sell	18,969 -5,252	-22%	-$165K	﹤0.01%	1527
2019 Q3	$752K	Sell	24,221 -10,150	-30%	-$309K	0.01%	1450
2019 Q2	$1.2M	Sell	34,371 -2,713	-7%	-$87.7K	0.01%	1268
2019 Q1	$1.09M	Sell	37,084 -493	-1%	-$14K	0.01%	1335
2018 Q4	$966K	Sell	37,577 -5,050	-12%	-$175K	0.01%	1404
2018 Q3	$1.5M	Buy	42,627 +7,731	+22%	+$308K	0.01%	1406
2018 Q2	$1.43M	Sell	34,896 -79,584	-70%	-$3.21M	0.01%	1436
2018 Q1	$4.49M	Sell	114,480 -21,712	-16%	-$796K	0.01%	1078
2017 Q4	$4.44M	Sell	136,192 -35,168	-21%	-$1.22M	0.01%	1100
2017 Q3	$8.18M	Buy	171,360 +3,820	+2%	+$186K	0.02%	774
2017 Q2	$8.27M	Buy	167,540 +5,284	+3%	+$234K	0.02%	741
2017 Q1	$7.07M	Buy	162,256 +119,168	+277%	+$4.84M	0.02%	831
2016 Q4	$1.43M	Buy	43,088 +37,243	+637%	+$1.45M	﹤0.01%	1921
2016 Q3	$290K	Buy	5,845 +957	+20%	+$49.8K	﹤0.01%	2565
2016 Q2	$271K	Sell	4,888 -2,109	-30%	-$123K	﹤0.01%	2585
2016 Q1	$386K	Sell	6,997 -2,616	-27%	-$149K	﹤0.01%	2466
2015 Q4	$600K	Sell	9,613 -7,138	-43%	-$465K	﹤0.01%	2350
2015 Q3	$1.11M	Buy	16,751 +12,299	+276%	+$946K	﹤0.01%	2032
2015 Q2	$349K	Buy	+4,452	New	+$320K	﹤0.01%	2646
2013 Q3	–	Sell	-18,902	Closed	-$625K	–	3058
2013 Q2	$625K	Buy	+18,902	New	+$613K	﹤0.01%	2313

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Guggenheim Capital's ACHC Position: Q1 2026 in Review

Guggenheim Capital reduced its Acadia Healthcare (ACHC) stake by 67% in Q1 2026, selling an estimated $772K and leaving 21,030 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Guggenheim Capital first reported a position in ACHC in Q2 2013 and has held it in 44 quarters since. The position peaked at $8.27M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Guggenheim Capital held 21,030 shares of Acadia Healthcare worth $492K as of Q1 2026.
Guggenheim Capital sold 42,663 Acadia Healthcare shares in Q1 2026, an estimated $772K.
Acadia Healthcare made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1209 holding.
Guggenheim Capital first reported a position in Acadia Healthcare in Q2 2013 and has held it in 44 quarters since.
Guggenheim Capital's Acadia Healthcare position peaked at $8.27M in Q2 2017.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.